Ad F. Roffel, N/A, PhD (he/him/his)

ICON plc

Ad Roffel is a Senior Director of Clinical Pharmacology at ICON. He is involved in advising and supporting our customers with respect to drug development, including the design of studies, PK and PD parameters, inclusion/exclusion criteria, and ethics. Focus areas have been thorough QT studies, respiratory medicine, and ¹⁴C microdosing and AME studies.

Presentation(s):

• Learning Lab | Key Considerations for Human ADME Studies and a Proposed Decision Tree for Tailored Study Designs brought to you by ICON

  Thursday, May 29, 2025
  10:40 AM - 10:55 AM East Coast USA Time

• Learning Lab | Key Considerations for Human ADME Studies and a Proposed Decision Tree for Tailored Study Designs brought to you by ICON

  Friday, May 30, 2025
  10:40 AM - 10:55 AM East Coast USA Time